The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes
Abstract
Information on the molecular distribution and ageing trend of brain iron in post-mortem material from normal subjects is scarce. Because it is known that neuromelanin and ferritin form stable complexes with iron(III), in this study we measured the concentration of iron, ferritin and neuromelanin in substantia nigra from normal subjects, aged between 1 and 90 years, dissected post mortem. Iron levels in substantia nigra were 20 ng/mg in the first year of life, had increased to 200 ng/mg by the fourth decade and remained stable until 90 years of age. The H-ferritin concentration was also very low (29 ng/mg) during the first year of life but increased rapidly to values of approximately 200 ng/mg at 20 years of age, which then remained constant until the eighth decade of life. L-Ferritin also showed an increasing trend during life although the concentrations were approximately 50% less than that of H-ferritin at each age point. Neuromelanin was not detectable during the first year, increased to approximately 1000 ng/mg in the second decade and then increased continuously to 3500 ng/mg in the 80th year. A Mössbauer study revealed that the high-spin trivalent iron is probably arranged in a ferritin-like iron--oxyhydroxide cluster form in the substantia nigra. Based on this data and on the low H- and L-ferritin content in neurones it is concluded that neuromelanin is the major iron storage in substantia nigra neurones in normal individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the substantia nigra, ferritin heavy chain and ferritin light chain concentrations increase with age, whereas these are constant in the locus coeruleus; therefore iron could contribute to neurodegeneration in the substantia nigra more than in the locus coeruleus.5,6”
From The role of iron in brain ageing and neurodegenerative disorders (2014) · cites this paper as [5]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. A., & SEITELBERGER, F. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90175-5 · Cited by 2,650
The effect of age on the non-haemin iron in the human brain
Hallgren, B., & Sourander, P. (1958) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1958.tb12607.x · Cited by 1,427
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Biochemical pathophysiology of Parkinson's disease.
Hornykiewicz, O., & Kish, S. J. (1987) · PubMed · Cited by 850
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P. F., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G. F., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 754
Aging and Extrapyramidal Function
McGeer, P. L., McGeer, E. G., & Suzuki, J. S. (1977) · Archives of Neurology · doi:10.1001/archneur.1977.00500130053010 · Cited by 648
Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains
Connor, J. R., Menzies, S. L., Martin, S. M. S., & Mufson, E. J. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270421 · Cited by 472
Research works printed but not linked: 2
- Moos T., 2000, Absence of ferritin protein in substantia nigra pars compacta neurons. A reappraisal to the role of iron in Parkinson disease pathogenesis, Mov. Disord., 15, 319A
- Zareba M., 1995, The effect of synthetic neuromelanin on yeld of free hydroxyl radicals generated in model system, Biochim. Biophys. Acta, 1138, 6
Cited by
Sorted by citations
Items 201–300 of 402
Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 36
Considerations for measuring iron in post-mortem tissue of Parkinson’s disease patients
Hare, D. J., Gerlach, M., & Riederer, P. F. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0898-4 · Cited by 35
Changes in iron-regulatory proteins in the aged rodent neural retina
Chen, H., Liu, B., Lukas, T. J., Suyeoka, G. M., Wu, G., & Neufeld, A. H. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.002 · Cited by 36
Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease
Miyazaki, I., & Asanuma, M. (2023) · Antioxidants · doi:10.3390/antiox12040894 · Cited by 36
Walker, T. A., Michaelides, C., Ekonomou, A., Geraki, K., Parkes, H. G., Suessmilch, M., Herlihy, A. H., Crum, W. R., & So, P. (2016) · Aging · doi:10.18632/aging.101069 · Cited by 36
Liu, C., Zhang, C., Lo, S. Q., Ang, S. T., Chew, K. C. M., Yu, D., Chai, B. H., Tan, B. C. Y., Tsang, F., Tai, Y. K., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3262-17.2018 · Cited by 34
Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease
Krainc, T., Monje, M. H. G., Kinsinger, M., Bustos, B. I., & Lubbe, S. J. (2022) · Movement Disorders · doi:10.1002/mds.29260 · Cited by 35
Schroeder, R. L., Double, K. L., & Gerber, C. (2015) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2015.02.001 · Cited by 34
Lancione, M., Donatelli, G., Prete, E. D., Campese, N., Frosini, D., Cencini, M., Costagli, M., Biagi, L., Lucchi, G., Tosetti, M., et al. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119454 · Cited by 33
Ferroptosis and pathogenesis of neuritic plaques in Alzheimer disease
Streit, W. J., Phan, L. T., & Bechmann, I. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.000823 · Cited by 36
Neonatal Iron Treatment Increases Apoptotic Markers in Hippocampal and Cortical Areas of Adult Rats
Miwa, C., de Lima, M. N. M., Scalco, F. S., Vedana, G., Mattos, R., Fernandez, L. L., Hilbig, A., Schröder, N., & Vianna, M. R. M. R. (2010) · Neurotoxicity Research · doi:10.1007/s12640-010-9181-3 · Cited by 34
Ferrari, E., Engelen, M., Monzani, E., Sturini, M., Girotto, S., Bubacco, L., Zecca, L., & Casella, L. (2012) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-012-0951-7 · Cited by 34
Metal Ions in Alzheimer's Disease Brain
Sastre, M., Ritchie, C. W., & Hajji, N. (2015) · Cited by 33
Substantia Nigra Volumetry with 3-T MRI in De Novo and Advanced Parkinson Disease
Vitali, P., Pan, M., Palesi, F., Germani, G., Faggioli, A., Anzalone, N., Francaviglia, P., Minafra, B., Zangaglia, R., Pacchetti, C., et al. (2020) · Radiology · doi:10.1148/radiol.2020191235 · Cited by 33
Recent advances in dopamine D 2 receptor ligands in the treatment of neuropsychiatric disorders
Jůza, R., Musílek, K., Mezeiová, E., Soukup, O., & Korábečný, J. (2022) · Medicinal Research Reviews · doi:10.1002/med.21923 · Cited by 34
Theoretical analysis of the adsorption of metal ions to the surface of melanin particles
Bridelli, M. G., & Crippa, P. R. (2007) · Adsorption · doi:10.1007/s10450-007-9059-8 · Cited by 33
Bautista, E., Vergara, P., & Segovia, J. (2015) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2015.11.005 · Cited by 33
Biel, D., Steiger, T. K., & Bunzeck, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-88840-1 · Cited by 38
Looking for biogenic magnetite in brain ferritin using NMR relaxometry
Gossuin, Y., Hautot, D., Müller, R. N., Pankhurst, Q. A., Dobson, J., Morris, C. M., Gillis, P., & Collingwood, J. F. (2005) · NMR in Biomedicine · doi:10.1002/nbm.983 · Cited by 32
Maresca, V., Flori, E., Cardinali, G., Briganti, S., Lombardi, D., Mileo, A. M., Paggi, M. G., & Picardo, M. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20543 · Cited by 31
Changing iron content of the mouse brain during development
Holmes‐Hampton, G. P., Chakrabarti, M., Cockrell, A. L., McCormick, S. P., Abbott, L. C., Lindahl, L. S., & Lindahl, P. A. (2012) · Metallomics · doi:10.1039/c2mt20086d · Cited by 31
Bica, L., Crouch, P. J., Cappai, R., & White, A. R. (2008) · Molecular BioSystems · doi:10.1039/b816577g · Cited by 33
α-synuclein and Parkinson’s disease: a proteomic view
Fasano, M., & Lopiano, L. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.2.239 · Cited by 31
Altered regulation of iron transport and storage in Parkinson’s disease
Hirsch, É. C. (2006) · Springer eBooks · doi:10.1007/978-3-211-33328-0_21 · Cited by 30
Iron and glutathione at the crossroad of redox metabolism in neurons
Aracena-Parks, P., Aguirre, P., Muñoz, P., & Núñez, M. T. (2006) · Biological Research · doi:10.4067/s0716-97602006000100017 · Cited by 28
Bergtold, C., Hauser, D., Chaumont, A., Yakhlifi, S. E., Mateescu, M., Meyer, F., Metz‐Boutigue, M., Frisch, B., Schaaf, P., Ihiawakrim, D., et al. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00818 · Cited by 28
Age-related variability in decision-making: Insights from neurochemistry
Berry, A. S., Jagust, W. J., & Hsu, M. (2018) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-018-00678-9 · Cited by 28
Synucleinopathies: a pathological and molecular review
Murray, I. V. J., Lee, V. M. ‐., & Trojanowski, J. Q. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00023-8 · Cited by 28
Protective effects of 1α,25-Dihydroxyvitamin D3 on cultured neural cells exposed to catalytic iron
Uberti, F., Morsanuto, V., Bardelli, C., & Molinari, C. G. (2016) · Physiological Reports · doi:10.14814/phy2.12769 · Cited by 27
Model Senescent Microglia Induce Disease Related Changes in α-Synuclein Expression and Activity
Angelova, D. M., & Brown, D. R. (2018) · Biomolecules · doi:10.3390/biom8030067 · Cited by 30
RETRACTED: Characterising the spatial and temporal brain metal profile in a mouse model of tauopathy
Rao, S. S., Lago, L., de Vega, R. G., Bray, L., Hare, D. J., Clases, D., Doble, P., & Adlard, P. A. (2019) · Metallomics · doi:10.1039/c9mt00267g · Cited by 27
RetractedIto, H., Kawaguchi, H., Kodaka, F., Takuwa, H., Ikoma, Y., Shimada, H., Kimura, Y., Seki, C., Kubo, H., Ishii, S., et al. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.06.066 · Cited by 27
Aluminium and iron in the brain—prospects for chelation
Crichton, R. R., Florence, A., & Ward, R. J. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00038-3 · Cited by 27
Increased dopamine peroxidation in postmortem Parkinsonian brain
Iuliis, A. D. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00331-8 · Cited by 27
Pheomelanin in the secondary sexual characters of male parasitoid wasps (Hymenoptera: Pteromalidae)
Jorge, A., Polidori, C., & Nieves‐Aldrey, J. L. (2016) · Arthropod Structure & Development · doi:10.1016/j.asd.2016.05.001 · Cited by 29
Palomo, T., Beninger, R. J., Kostrzewa, R. M., & Archer, T. (2003) · Neurotoxicity Research · doi:10.1007/bf03033369 · Cited by 26
VanLandingham, J. W., & Levenson, C. W. (2003) · Nutritional Neuroscience · doi:10.1080/1028415021000056041 · Cited by 25
Resistive switching controlled by the hydration level in thin films of the biopigment eumelanin
Mauro, E. D., Carpentier, O., Sánchez, S. I. Y., Ignoumba, N. I., Myriam, L.-J., Lefebvre, J., Zhang, S., Graeff, C. F. O., Cicoira, F., & Santato, C. (2016) · Journal of Materials Chemistry C · doi:10.1039/c6tc02793h · Cited by 25
The Neuromelanin-related T2* Contrast in Postmortem Human Substantia Nigra with 7T MRI
Lee, J., Baek, S., Song, Y., Lim, S., Lee, H., Nguyen, M. P., Kim, E., Huh, G. Y., Chun, S. Y., & Cho, H. (2016) · Scientific Reports · doi:10.1038/srep32647 · Cited by 25
Age modulates the injury-induced metallomic profile in the brain
Portbury, S. D., Hare, D. J., Sgambelloni, C., Bishop, D., Finkelstein, D. I., Doble, P., & Adlard, P. A. (2017) · Metallomics · doi:10.1039/c6mt00260a · Cited by 25
Magnetic domains oscillation in the brain with neurodegenerative disease
Kletetschka, G., Bazala, R., Takáč, M., & Svecova, E. (2021) · Scientific Reports · doi:10.1038/s41598-020-80212-5 · Cited by 25
Aguirre, P., Valdés, P., Aracena-Parks, P., Tapia, V., & Núñez, M. T. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00620.2006 · Cited by 25
Modi, G. P., Voshavar, C., Gogoi, S., Shah, M. M., Antonio, T., Reith, M. E. A., & Dutta, A. K. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500084x · Cited by 24
Element imaging in formalin fixed slices of human mesencephalon
Matusch, A., Bauer, A., & Becker, J. S. (2011) · International Journal of Mass Spectrometry · doi:10.1016/j.ijms.2011.03.006 · Cited by 24
Gałązka-Friedman, J., Friedman, A., & Bauminger, E. R. (2009) · Hyperfine Interactions · doi:10.1007/s10751-009-9926-7 · Cited by 23
Brooks, J., Everett, J. L., Lermyte, F., Tjhin, V. T., Sadler, P. J., Telling, N. D., & Collingwood, J. F. (2020) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2020.126555 · Cited by 23
Tripathi, S., Mahdi, A. A., Hasan, M. N., Mitra, K., & Mahdi, F. (2011) · PubMed · Cited by 23
Cell-Protein-Material Interaction in Tissue Engineering
Salmerón‐Sánchez, M., & Altankov, G. (2010) · InTech eBooks · doi:10.5772/8584 · Cited by 22
Does ultrasound disclose a vulnerability factor for Parkinson's disease?
Behnke, S., Berg, D., & Becker, G. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1104-0 · Cited by 22
Iron Oxides in the Human Brain
Collingwood, J. F., & Telling, N. D. (2016) · doi:10.1002/9783527691395.ch7 · Cited by 22
Imaging Parkinsonian Pathology in Substantia Nigra with MRI
Huddleston, D. E., Langley, J. A., Dušek, P., He, N., Faraco, C. C., Crosson, B., Factor, S. A., & Hu, X. P. (2018) · Current Radiology Reports · doi:10.1007/s40134-018-0272-x · Cited by 21
Juan, S. M. A., Daglas, M., & Adlard, P. A. (2022) · Journal of Neurotrauma · doi:10.1089/neu.2021.0241 · Cited by 21
Iron, Aging, and Neurodegeneration
Angelova, D. M., & Brown, D. R. (2015) · Metals · doi:10.3390/met5042070 · Cited by 23
Enge, T. G., Ecroyd, H. W., Jolley, D. F., Yerbury, J. J., & Dosseto, A. (2016) · Metallomics · doi:10.1039/c6mt00270f · Cited by 22
Cytotoxicity of paramagnetic cations—Loaded polydopamine nanoparticles
Vega, M. A., Nieto, C., Marcelo, G., & del Valle, E. M. M. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.04.027 · Cited by 21
The Pharmacokinetics and Toxicology of Aluminum in the Brain
Yokel, R. A. (2012) · Current Inorganic Chemistry · doi:10.2174/1877944111202010054 · Cited by 21
Jellinger, K. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_15 · Cited by 22
Mössbauer spectroscopy in biomedical research
Oshtrakh, M. I. (2003) · Faraday Discussions · doi:10.1039/b304906j · Cited by 21
Glia Protects Neurons against Extracellular Human Neuromelanin
Depboylu, C., Matusch, A., Tribl, F., Zoriy, M. V., Michel, P. P., Riederer, P. F., Gerlach, M., Becker, S., Oertel, W. H., & Höglinger, G. U. (2007) · Neurodegenerative Diseases · doi:10.1159/000101846 · Cited by 21
Sharma, M., Sharma, N., & Khairnar, A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03847-y · Cited by 20
Zhang, Q., CHENG-WU, L., Zhang, T., Ge, Y., Han, X., Sun, S., Ding, J., Lu, M., & Hu, G. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.08.006 · Cited by 21
Cross-Scanner Harmonization of Neuromelanin-Sensitive MRI for Multisite Studies
Wengler, K., Cassidy, C., van der Pluijm, M., Weinstein, J., Abi-Dargham, A., van de Giessen, E. M., & Horga, G. (2021) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27679 · Cited by 21
Proteomic studies associated with Parkinson’s disease
Kasap, M., Akpınar, G., & Kanlı, A. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1291344 · Cited by 20
Wu, K., Liou, H., Lee, C.-Y., & Lin, C. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12493 · Cited by 18
Changes in cytoplasmic and extracellular neuromelanin in human substantia nigra with normal aging
Korzhevsky, D. E., Kirik, O. V., Гусельникова, В. В., Цыба, Д. Л., Fedorova, E. A., & Grigor’ev, I. P. (2021) · European Journal of Histochemistry · doi:10.4081/ejh.2021.3283 · Cited by 19
Schneider, S. A., Zorzi, G. S., & Nardocci, N. (2013) · Current Treatment Options in Neurology · doi:10.1007/s11940-013-0254-5 · Cited by 18
Proteomics as a tool to investigate cell models for dopamine toxicity
Fasano, M., Alberio, T., Colapinto, M., Mila, S., & Lopiano, L. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.04.016 · Cited by 17
Applications of Mössbauer Spectroscopy in Biomedical Research
Oshtrakh, M. I. (2018) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-018-0843-8 · Cited by 17
Wang, J., Wang, Y., Lv, H., Hui, F., Ma, Y., Lu, S., Sha, Q., & Wang, E. (2006) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2006.05.021 · Cited by 17
Wang, P., Chen, Q., Tang, Z., Wang, L., Gong, B., Li, M., Li, S., & Yang, M. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1231707 · Cited by 16
Ferroptosis—A Shared Mechanism for Parkinson’s Disease and Type 2 Diabetes
Duţă, C., Muscurel, C., Dogaru, C. B., & Stoian, I. A.-M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168838 · Cited by 19
Longitudinal neuromelanin changes in prodromal and early Parkinson’s disease in humans and rat model
Pérot, J., Ruze, A., Gaurav, R., Rebbah, S., Cadin, C., Troter, A. L., Soustelle, L., Mouton, L., Valabrègue, R., Parent, A., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf204 · Cited by 17
Rôles biologiques des éléments traces dans le cerveau – exemples du Zn et du Fe
Bohic, S., Ghersi‐Egea, J., Gibon, J., Paoletti, P., Arnaud, J., Hunot, S., Boom, A., & Bouron, A. (2010) · Revue Neurologique · doi:10.1016/j.neurol.2010.07.035 · Cited by 16
Impact of Autophagy and Aging on Iron Load and Ferritin in Drosophila Brain
Jacomin, A., Geraki, K., Brooks, J., Tjhin, V. T., Collingwood, J. F., & Nezis, I. P. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00142 · Cited by 16
Iron as a trigger of neurodegeneration in Parkinson's disease
Friedman, A., Gałązka-Friedman, J., & Bauminger, E. R. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)83023-5 · Cited by 16
Ward, W. C., & Simon, J. D. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00357.x · Cited by 16
Oxidative Stress in Parkinson's Disease
Vaya, J., Aluf, Y., & Finberg, J. P. M. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-514-9_12 · Cited by 16
Samokhvalov, A., Liu, Y., & Simon, J. D. (2004) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2004.tb00053.x · Cited by 16
Wang, E. W., Brown, G. L., Lewis, M. M., Jellen, L. C., Pu, C., Johnson, M. L., Chen, H., Kong, L., Du, G., & Huang, X. (2023) · Movement Disorders · doi:10.1002/mds.29311 · Cited by 15
Quiescence induced by iron challenge protects neuroblastoma cells from oxidative stress
Mura, C. V., Delgado, R., Aguirre, P., Bacigalupo, J., & Núñez, M. T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03798.x · Cited by 15
Walter, U. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.41 · Cited by 15
Al-Amin, M., Zehravi, M., Sweilam, S. H., Shatu, M. M., Durgawale, T. P., Qureshi, M. S., Durgapal, S., Haque, M. A., Vodeti, R., Panigrahy, U. P., et al. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149693 · Cited by 17
Catecholaminergic neurons of mammalian brain and neuromelanin
Sukhorukova, E. G., Alekseeva, O. S., & Korzhevsky, D. E. (2014) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093014050020 · Cited by 14
Shackelford, R. E., Manuszak, R. P., Heard, S. C., Link, C. J., & Wang, S. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.08.029 · Cited by 14
Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology
Currim, F., Tanwar, R., Brown-Leung, J. M., Paranjape, N., Liu, J., Sanders, L. H., Doorn, J. A., & Cannon, J. R. (2024) · NeuroToxicology · doi:10.1016/j.neuro.2024.06.016 · Cited by 14
Vano, L. J., McCutcheon, R. A., Sedlacik, J., Kaar, S. J., Rutigliano, G., Nordio, G., Finelli, V., Townsend, L., Berry, A., Statton, B. K., et al. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20240512 · Cited by 13
The influence of iron on selected properties of synthetic pheomelanin
Żądło, A. C., Mokrzynski, K. T., Ito, S., Wakamatsu, K., & Sarna, T. (2020) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-020-00918-1 · Cited by 13
Luo, J., & Collingwood, J. F. (2022) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2022.109708 · Cited by 13
Assessment of Melanin Content and its Influence on Susceptibility Contrast in Melanoma Metastases
Straub, S., Laun, F. B., Freitag, M. T., Koelsche, C., von Deimling, A., Denoix, M., Bendszus, M., Schlemmer, H.-P., Ladd, M. E., & Schneider, T. M. (2019) · Clinical Neuroradiology · doi:10.1007/s00062-019-00816-x · Cited by 13
Capucciati, A., Monzani, E., Sturini, M., Nicolis, S., Zucca, F. A., Bubacco, L., Bortolus, M., Zecca, L., & Casella, L. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202204787 · Cited by 12
Changes in Metabolism and Proteostasis Drive Aging Phenotype in Aplysia californica Sensory Neurons
Kron, N. S., Schmale, M. C., & Fieber, L. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.573764 · Cited by 13
Götz, M. E., & Gerlach, M. (2004) · Springer eBooks · doi:10.1007/1-4020-2541-6_10 · Cited by 12
Aging-induced alterations in microglial cells and their impact on neurodegenerative disorders
Singh, H., Gupta, R., Gupta, M., & Ahmad, A. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10623-y · Cited by 11
Raab, P., Ropele, S., Bültmann, E., Salcher, R. B., Lanfermann, H., & Wattjes, M. P. (2021) · Neuroradiology · doi:10.1007/s00234-021-02846-0 · Cited by 11
Iron as a risk factor in neurological diseases
Gałązka-Friedman, J. (2008) · Hyperfine Interactions · doi:10.1007/s10751-008-9723-8 · Cited by 11
Kwon, K., Cho, H., Lee, S.-Y., Cho, E. J., Yu, W., Kok, C. Y. L., Je, H. S., Kim, J., Cho, H. J., & Kwon, T. (2022) · Aging Cell · doi:10.1111/acel.13694 · Cited by 9
Neuromelanin inhibits CXCL10 expression in human astroglial cells
Tousi, N. S., Buck, D. J., Zecca, L., & Davis, R. L. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.09.042 · Cited by 11
The effect of neuromelanin on the proteasome activity in human dopaminergic SH-SY5Y cells
Maruyama, W., Shamoto‐Nagai, M., Akao, Y., Riederer, P. F., & Naoi, M. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_20 · Cited by 11
Ferritin H- and L-Chains in Fiber Cell Canine and Human Lenses of Different Ages
Goralska, M., Fleisher, L. N., & McGahan, M. C. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0130 · Cited by 10
Tracemetals, neuromelanin and neurodegeneration: An interesting area for research
Rao, T. S., Zecca, L., & Rao, K. J. (2007) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.37310 · Cited by 10
Metadata
- Authors
- Zecca, L., Gallorini, M., Schünemann, V., Trautwein, A. X., Gerlach, M., Riederer, P., Vezzoni, P., & Tampellini, D.
- Affiliations
- Institute of Biomedical Technologies (IT)
- University of Pavia (IT)
- University of Lübeck (DE)
- University of Würzburg (DE)
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2001-03-15
- Volume
- 76
- Issue
- 6
- Pages
- 1766-1773
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1601438958
- Cited by
- 401
- References
- 61
- Citations by year
- 2026: 7 · 2025: 16 · 2024: 11 · 2023: 13 · 2022: 19 · 2021: 25 · 2020: 13 · 2019: 20 · 2018: 23 · 2017: 18 · 2016: 19 · 2015: 10 · 2014: 14 · 2013: 17 · 2012: 14
- FWCI
- 8.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Fondazione Cariplo
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- brain iron, substantia nigra, neuromelanin, ferritin, iron storage, aging, neurodegeneration, high-spin iron, postmortem brain
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aging, Child, Child, Preschool, Ferritins, Humans, Infant, Iron, Melanins, Middle Aged, Nerve Degeneration, Reference Values, Substantia Nigra
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review